An open-label phase 1 study of E7386 in subjects with advanced solid tumor including colorectal cancer
NCT ID NCT03833700
Summary
This study will be conducted to assess the safety and tolerability of E7386 in participants with solid tumor including CRC.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Eisai Trial Site #1
Chuo Ku, Tokyo, Japan
-
Eisai Trial Site #2
Kashiwa, Chiba, Japan
-
Eisai Trial Site #3
Nagaizumi-cho, Shizuoka, Japan
-
Eisai Trial Site #4
Fukuoka, Japan
-
Eisai Trial Site #5
Sapporo, Hokkaido, Japan
-
Eisai Trial Site#6
Osaka, Japan
-
Eisai Trial Site#7
Nagoya, Aichi-ken, Japan
-
Eisai Trial Site#8
Sendai, Miyagi, Japan
Conditions
Explore the condition pages connected to this study.